Consolidated Statements of Operations (Unaudited) - USD ($)	3 Months Ended		9 Months Ended
	Mar. 31, 2017	Mar. 31, 2016	Mar. 31, 2017	Mar. 31, 2016
Revenue		$ 3,658		$ 3,658
Operating expenses:
General and administrative (including stock-based compensation (Note 7))	401,346	501,584	1,352,734	1,559,584
Depreciation	502	68,992	1,507	220,954
Research and development (including stock-based compensation (Note 7))	85,802	63,376	324,127	282,151
Total operating expenses	487,650	633,952	1,678,368	2,062,689
Loss from operations	(487,650)	(630,294)	(1,678,368)	(2,059,031)
Other expense:
Interest expense, net	94,640	89,170	281,969	290,831
Total other expense	94,640	89,170	281,969	290,831
Net loss	(582,290)	(719,464)	(1,960,337)	(2,349,862)
Net loss attributable to the noncontrolling interest	508	532	1,904	3,101
Net loss applicable to Bion's common stockholders	$ (581,782)	$ (718,932)	$ (1,958,433)	$ (2,346,761)
Net loss applicable to Bion's common stockholders per basic and diluted common share (in dollars per share)	$ (0.02)	$ (0.03)	$ (0.08)	$ (0.10)
Basic and diluted (in shares)	23,348,981	22,888,963	23,407,626	22,588,552